Prosecution Insights
Last updated: April 19, 2026
Application No. 17/461,651

AUTOMATICALLY IDENTIFYING SCAR AREAS WITHIN ORGANIC TISSUE USING MULTIPLE IMAGING MODALITIES

Non-Final OA §101
Filed
Aug 30, 2021
Examiner
WELCH, WILLOW GRACE
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
BIOSENSE WEBSTER (ISRAEL) LTD.
OA Round
7 (Non-Final)
45%
Grant Probability
Moderate
7-8
OA Rounds
3y 3m
To Grant
95%
With Interview

Examiner Intelligence

Grants 45% of resolved cases
45%
Career Allow Rate
22 granted / 49 resolved
-25.1% vs TC avg
Strong +50% interview lift
Without
With
+50.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
39 currently pending
Career history
88
Total Applications
across all art units

Statute-Specific Performance

§101
23.0%
-17.0% vs TC avg
§103
40.2%
+0.2% vs TC avg
§102
16.1%
-23.9% vs TC avg
§112
18.3%
-21.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 49 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 01/16/2026 has been entered. Response to Arguments Applicant's arguments filed on 01/16/2026 have been fully considered but they are not persuasive. 35 USC 101 Applicant argues that the claims are not directed to an abstract idea and are instead directed to a method of predicting the location of ablation using data from before the procedure and during the procedure. Examiner respectfully disagrees and maintains that the claims are directed to the abstract idea of locating an origin of arrhythmia and indicating an optimal ablation site. Specifically, Applicant argues that the feedback recited in the claims is not performed by a human and therefore cannot be performed in the human mind. Examiner respectfully disagrees and notes that as currently written, the claims require a generic computer component (processor) to verify an outcome and receive feedback regarding that outcome. Claims can recite a mental process even if they are claimed as being performed on a computer. The Supreme Court recognized this in Benson, determining that a mathematical algorithm for converting binary coded decimal to pure binary within a computer’s shift register was an abstract idea. The Court concluded that the algorithm could be performed purely mentally even though the claimed procedures "can be carried out in existing computers long in use, no new machinery being necessary." 409 U.S at 67, 175 USPQ at 675 (MPEP 2106.04(a)(2)(III)). Merely providing instructions to perform an abstract idea on a generic computer components fails to amount to significantly more. Applicant further argues that the claims are also directed to a method to perform an ablation to treat an arrhythmia. Examiner respectfully disagrees and notes that as currently written, the claims do not positively recite the step of performing an ablation or any structure capable of performing an ablation. The claims only require gathering data prior to and after initiation of an ablation. Examiner suggests amending the claims to recite the particular treatment of performing an ablation in order to help overcome the pending 101 rejection. Applicant’s arguments, see pages 7-13, filed on 01/16/2026, with respect to claims 1 and 11 have been fully considered and are persuasive. The prior art rejection of claims 1 and 11 has been withdrawn. Claim Objections Claims 1 and 11 are objected to because of the following informalities: Claims 1 and 11 both recite acronyms (ECG, MRI, ICEG, etc.) without first reciting the full term. Examiner suggests amending the claims to first recite the full term and then the acronym. Appropriate correction is respectfully requested. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-20 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea (mental process of locating an origin of arrhythmia and indicating an optimal ablation site) without significantly more. Step 1 The claimed invention in claims 1-20 are directed to statutory subject matter as the claims recite a method/system for of locating an origin of arrhythmia and indicating an optimal ablation site. Step 2A, Prong One Regarding claims 1-20, the recited steps are directed to mental processes of performing concepts in a human mind or by a human using a pen and paper (See MPEP 2106.05(a)(2) subsection (III)). Regarding claims 1 and 11 the limitations of “registering the first set of data to a coordinate system of the second set of data”, “generating, based on the registered first and second sets of data, an optimal location…”, “outputting the optimal location…”, and “training the optimal location generation using feedback…” are a process, as drafted, that can be performed by a human mind (including an observation, evaluation, and judgment) but for the recitation of generic computing components under the broadest reasonable interpretation. Step 2A, Prong Two For claims 1-20, the judicial exception is not integrated into a practical application. For claims 1 and 11, the additional limitation of an “Input/Output device” and a “processor” are recited at a high level of generality and amount to nothing more than parts of a generic computer. Merely including instructions to implement an abstract idea on a computer does not integrate a judicial exception into a practical application. Further, the limitation of “receiving at least a first set of data…and a second set of data…” amounts to nothing more than the pre-solution activity of data gathering while the limitation of “outputting the optimal location” amounts to nothing more than the post-solution activity of providing results (MPEP 2106.05(g)). Step 2B The claims do not include additional elements that are sufficient enough to amount to significantly more than the judicial exception. As discussed above with respect to integration of the abstract idea into a practical application, the additional limitations of “receiving at least a first set of data…and a second set of data…” and “outputting the optimal location” amount to nothing more than extra-solution activities and fail to integrate the abstract idea into a practical application. In addition, the ECG leads, ICEG, MRI, CT and CS Catheter are recited at a high level of generality and considered to be well known, routine, and conventional in the art. Examples: CS catheter Gillberg et al (US Publication 2012/0165811) [0018] Pachon Mateos et al (US Publication 2007/0038251) ECG Gillberg et al (US Publication 2012/0165811) [0026] Keidar (US Publication 2004/0078036) [0024] CT Federov et al (US Publication 2022/0346856) [0025] Keidar (US Publication 2004/0078036) [0038] MRI Ciaccio (US Publication 2009/0099563) [0012] Federov et al (US Publication 2022/0346856) [0025] ICEG Ciaccio (US Publication 2009/0099563) [0044] Keidar (US Publication 2004/0078036) [0007] Dependent claims 2-6, 10, 12-16, and 20 are further directed to the abstract idea and do not introduce any additional elements that amount to significantly more under the Step 2A and Step 2B analyses. Dependent claims 7-9 and 17-19 are directed towards extra-solution activities (MPEP 2106.05(g)) and do not introduce any additional elements that amount to significantly more under the Step 2A and Step 2B analyses. Examiner’s Note Regarding Prior Art Examiner notes that claims 1-20 are rejected under 35 USC 101, however no prior art rejections have been made. The following is a statement of reasons for the indication of allowable subject matter: Examiner has not found prior art that teaches or suggests in combination the limitations recited in claims 1 and 11. Ciaccio discloses indicating origins for non-sustained tachycardia [0013], but fails to teach: receiving at least a first set of data measured prior to performing the ablation and collected using at least ECG leads, and at least a second set of data measured after initiation of the ablation by at least one of an ECG, an ICEG, MRI, CT and CS catheter; registering the first set of data to a coordinate system of the second set of data; generating, based on the registered first and second sets of data, an optimal location within a heart for performing an ablation to treat the arrythmia with non- sustained tachycardia, the optimal location being based on a voxel determined to be the origin of the arrythmia; outputting the optimal location for performing the ablation by displaying the heart with an indication of the optimal location; and training the optimal location generation using feedback based on a verified clinical outcome of the ablation performed at the output optimal location, the feedback including the outcome of the ablation measured both during the ablation and after ablation associated with the received first set of data. Trayanova et al (US 2023/0363689) discloses: receiving at least a first set of data measured prior to performing the pacing and collected using at least ECG leads [0033], and at least a second set of data measured after initiation of the pacing by at least one of an ECG, an ICEG, MRI, CT and CS catheter [0034]; registering the first set of data to a coordinate system of the second set of data [0039]; generating, based on the registered first and second sets of data, an optimal location within a heart for performing an ablation to treat the arrythmia [0040]; outputting the optimal location for performing the ablation by displaying the heart with an indication of the optimal location (Fig. 4). Trayanova fails to disclose: receiving at least a first set of data measured prior to performing the ablation and collected using at least ECG leads, and at least a second set of data measured after initiation of the ablation by at least one of an ECG, an ICEG, MRI, CT and CS catheter; registering the first set of data to a coordinate system of the second set of data; generating, based on the registered first and second sets of data, an optimal location within a heart for performing an ablation to treat the arrythmia with non- sustained tachycardia, the optimal location being based on a voxel determined to be the origin of the arrythmia; outputting the optimal location for performing the ablation by displaying the heart with an indication of the optimal location; and training the optimal location generation using feedback based on a verified clinical outcome of the ablation performed at the output optimal location, the feedback including the outcome of the ablation measured both during the ablation and after ablation associated with the received first set of data. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Trayanova et al (US 2023/0363689) is directed towards pacing the heart at an origin of idiopathic ventricular arrhythmia. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WILLOW GRACE WELCH whose telephone number is (703)756-1596. The examiner can normally be reached Usually M-F 8:00am - 4:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Benjamin Klein can be reached at 571-270-5213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WILLOW GRACE WELCH/Examiner, Art Unit 3792 /Benjamin J Klein/Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Aug 30, 2021
Application Filed
Dec 21, 2023
Non-Final Rejection — §101
Mar 27, 2024
Response Filed
Apr 11, 2024
Final Rejection — §101
Jul 30, 2024
Request for Continued Examination
Jul 31, 2024
Response after Non-Final Action
Aug 12, 2024
Non-Final Rejection — §101
Nov 14, 2024
Response Filed
Jan 06, 2025
Final Rejection — §101
Apr 09, 2025
Request for Continued Examination
Apr 10, 2025
Response after Non-Final Action
May 18, 2025
Non-Final Rejection — §101
Sep 02, 2025
Response Filed
Oct 08, 2025
Final Rejection — §101
Jan 16, 2026
Request for Continued Examination
Feb 05, 2026
Response after Non-Final Action
Mar 02, 2026
Non-Final Rejection — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12551163
System and Method for Noninvasive Sleep Monitoring and Reporting
2y 5m to grant Granted Feb 17, 2026
Patent 12551165
ELECTROCARDIOGRAM LEAD GUIDE SYSTEM AND METHOD
2y 5m to grant Granted Feb 17, 2026
Patent 12508425
BILATERAL VAGUS NERVE STIMULATION
2y 5m to grant Granted Dec 30, 2025
Patent 12427314
NEUROMODULATION OF THE GLOSSOPHARYNGEAL NERVE TO IMPROVE SLEEP DISORDERED BREATHING
2y 5m to grant Granted Sep 30, 2025
Patent 12419713
SURGICAL INSTRUMENT WITH SENSOR ALIGNED CABLE GUIDE
2y 5m to grant Granted Sep 23, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
45%
Grant Probability
95%
With Interview (+50.5%)
3y 3m
Median Time to Grant
High
PTA Risk
Based on 49 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month